News
Canine Cancer: New, Inexpensive Treatment Prolongs Life for Dogs with Hemangiosarcoma Tumors
Posted by I'm-Yunity® 🐾 on
Hemangiosarcoma is a relatively common canine cancer that affects 6-8% of all dogs in the United States. As dogs tolerate the tumors well until the late stages of the disease, the prognosis following diagnosis is poor. The average life expectancy following surgical intervention is 180 days. Chemotherapy in addition to surgery, the current standard of care, extends the average dog’s life a mere additional 180 days. Research is underway at several veterinary medical facilities to find a means of early diagnosis and treatment for this fatal cancer.
VETgirl Veterinary CE Blog
Posted by I'm-Yunity® 🐾 on
Mushroom I’m-Yunity used for the treatment of canine hemangiosarcoma
Mushroom Compound Offers Hope for Cancer in Dogs and Humans
Posted by I'm-Yunity® 🐾 on
Jeff Gillman and his German shepherd-husky mix dog Reuben have been together for 12 years, and now a deadly blood cancer threatens to separate them. “I got him the summer after my freshman year in college and I was traveling on the West Coast bumming around hitchhiking,” said the now 31-year-old lawyer from Philadelphia.
Researchers Shocked by Mushroom Study Results
Posted by I'm-Yunity® 🐾 on
In a study conducted at the University of Pennsylvania School of Veterinary Medicine and published recently in an open-access article in the journal Evidence-Based Complementary and Alternative Medicine, dogs with hemangiosarcoma — an aggressive, malignant cancer that develops in the cells of blood vessels — were given a compound derived from a type of mushroom, Coriolus versicolor.
UPenn Press Release
Posted by I'm-Yunity® 🐾 on
Compound Derived From a Mushroom Lengthens Survival Time in Dogs With Cancer
Research Report
Posted by I'm-Yunity® 🐾 on
Single Agent Polysaccharopeptide Delays Metastases and Improves Survival in Naturally Occurring Hemangiosarcoma